Trends and characteristics of extra-medical use of quetiapine among people who regularly inject drugs in Australia, 2011–2018
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 221, 108636
Abstract
No abstract availableKeywords
Funding Information
- Department of Health, Disability and Ageing
- National Drug and Alcohol Research Centre
- National Health and Medical Research Council (1136908)
- National Health and Medical Research Council (1174630)
This publication has 26 references indexed in Scilit:
- Prevalence and associations of quetiapine fumarate misuse among an Australian national city sample of people who regularly inject drugsAddiction, 2013
- Trends in quetiapine use and non‐fatal quetiapine‐related ambulance attendancesDrug and Alcohol Review, 2013
- Off-Label Use of Atypical AntipsychoticsCNS Drugs, 2012
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugsNature Reviews Endocrinology, 2011
- Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non‐adherence and aberrant medication‐related behavioursDrug and Alcohol Review, 2011
- Increasing off‐label use of antipsychotic medications in the United States, 1995–2008Pharmacoepidemiology and Drug Safety, 2011
- Antipsychotic prescribing trends: a review of pharmaco‐epidemiological studiesActa Psychiatrica Scandinavica, 2009
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studiesBMJ, 2007
- Intranasal Quetiapine AbuseAmerican Journal of Psychiatry, 2004
- ‘Crystal meth’ use among polydrug users in Sydney's dance party subculture: characteristics, use patterns and associated harmsInternational Journal of Drug Policy, 2003